Looking for our shop? click here


Our vision at MiProbes is to empower and educate people to know what healthy means to them.


We believe that in the future, people will measure and track not just their heart rate and step count, but all of their health vitals.


MiProbes is the first step to this future, by monitoring vitamins, minerals and substances through your urine. MiProbes allows you to make data-driven day-to-day health decisions about yourself. 


The days of having your health compared to an “average” on a difficult to read medical chart are over. You deserve to know what healthy means to you specifically and MiProbes is here to help.


CEO & Co-Founder

Dr. Nina Patrick


Dr. Augusta Modestino


CSO & Co-Founder

Dr. Nina Patrick is a health-curious scientist with a PhD in Bioengineering and Pharmaceutical Studies. In her PhD, Nina identified specific hormone imbalances caused by pharmaceutical drugs. She was driven to start this company to help these patients to learn of these imbalances and deficiencies in the comfort of their own home.

Dr. Augusta Modestino, also holds a PhD in Bioengineering from UCSD. Her expertise is in diagnostic assay tech-development. During her PhD, Augusta developed point-of-care diagnostic assays for coagulation and metabolic disorders. Augusta worked at Knight Cancer Institute at Oregon Health and Science University to develop technologies to enable early-cancer detection. 


Kachun To

Commercial Advisor

Kachun is a serial entrepreneur building and scaling businesses in Germany, Japan and China. He is an ex-McKinsey consultant and an expert on D2C businesses.


Declan O'Mahoney

Commercial Advisor

Declan is a technology CEO and Non Exec Director with multiple exits, history of fixing, growing and funding companies to international success.


Michael Jewett

Scientific Advisor

Mike is a Walter P. Murphy Professor of Chemical and Biological Engineering at Northwestern University, the most cited scientist in cell-free biology, and founder and scientific advisor to several biotech companies.